Consistently, Cxcr5 deletion in B-ALL stem cells showed survival advantages in a B-ALL murine model, while high expression of CXCR5 in pediatric B-ALL predicted central nervous system relapse [97]. Here, CXCR5 is linked to precursor B-cell acute lymphoblastic leukemia.